SCHEMBL3084243

SCHEMBL3084243

CN(CCc1ccc(Cl)c(CO[Si](C)(C)C(C)(C)C)c1)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
CCNE2 O96020 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
HTR2C P28335 2/20 0.34
SLC6A4 P31645 2/20 0.34
BACE1 P56817 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
FFAR1 O14842 2/20 0.33
FFAR4 Q5NUL3 2/20 0.33
GBA1 P04062 1/20 0.32
ESRRG P62508 1/20 0.32
GLS O94925 1/20 0.32
KAT6A Q92794 1/20 0.32
KAT5 Q92993 1/20 0.32
ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3075616 0.89 HTR2C (0.39) HTR2CSLC6A4BACE1MEN1KMT2A
SCHEMBL3087622 0.88 ADRB3 (0.35) CDK8CLK4BACE1MEN1KMT2A
SCHEMBL1750783 0.85 REN (0.35)
SCHEMBL1751384 0.84 ADRB3 (0.38) CDK8CLK4BACE1MEN1KMT2A
SCHEMBL3084246 0.83 CDK8 (0.42) CDK8CLK4CCNE2CCNE1CDK2
SCHEMBL3079714 0.81 HDAC3 (0.38) BACE1MEN1KMT2ALMNATSHR
SCHEMBL1751218 0.81 SSTR4 (0.35) BACE1
SCHEMBL20976378 0.79 GBA1 (0.32) CCNE2CCNE1CDK2HTR2CSLC6A4
SCHEMBL661522 0.79 ALDH1A1 (0.39) SLC6A4BACE1MEN1KMT2AALDH1A1
SCHEMBL1752399 0.78 REN (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324052-A1 NOVEL PIPERIDINE CARBOXYLIC ACID AMINE DERIVATIVES BEZENCON OLIVIER 2010-12-23 US disclosed
US-7799805-B2 Piperidine carboxylic acid amide derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2010-09-21 US disclosed
US-20080214598-A1 Novel Piperidine Carboxylic Acid Amide Derivatives ACTELION PHARMACEUTICALS LTD (CH) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214598-A1 Novel Piperidine Carboxylic Acid Amide Derivatives REN, ACE, AGTR2 CDK8 735/4885CLK4 2907/4885CCNE2 2844/4885
US-20100324052-A1 NOVEL PIPERIDINE CARBOXYLIC ACID AMINE DERIVATIVES REN, ACE, AGTR2 CDK8 944/4885CLK4 2664/4885CCNE2 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.